These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10147674)

  • 1. Physical properties of antibiotic aerosols produced by jet and ultrasonic nebulizers.
    Takanami C; Goto Y
    J Aerosol Med; 1990; 3(1):45-52. PubMed ID: 10147674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
    Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
    Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design principles of liquid nebulization devices currently in use.
    Rau JL
    Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nebulizer type and antibiotic concentration on device performance.
    Weber A; Morlin G; Cohen M; Williams-Warren J; Ramsey B; Smith A
    Pediatr Pulmonol; 1997 Apr; 23(4):249-60. PubMed ID: 9141110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparison of five nebulizers during noninvasive ventilation: analysis of inhaled and lost doses.
    Michotte JB; Jossen E; Roeseler J; Liistro G; Reychler G
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):430-40. PubMed ID: 24517084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizers.
    Asmus MJ; Milavetz G; Tice AL; Teresi ME
    Pharmacotherapy; 2001 May; 21(5):534-9. PubMed ID: 11349742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.
    McCallion ON; Taylor KM; Thomas M; Taylor AJ
    Pharm Res; 1995 Nov; 12(11):1682-8. PubMed ID: 8592670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers.
    Steckel H; Eskandar F
    Eur J Pharm Sci; 2003 Aug; 19(5):443-55. PubMed ID: 12907295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
    Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
    Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation.
    Harvey CJ; O'Doherty MJ; Page CJ; Thomas SH; Nunan TO; Treacher DF
    Eur Respir J; 1997 Apr; 10(4):905-9. PubMed ID: 9150333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Time course of drug concentrations in nebulizers and nebulized solutions].
    Ito K; Kikuchi S; Yamada M; Torii S; Yoshida M
    Arerugi; 1992 Jul; 41(7):772-7. PubMed ID: 1444830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration.
    Phipps PR; Gonda I
    Chest; 1990 Jun; 97(6):1327-32. PubMed ID: 2347217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
    O'Riordan TG; Amram JC
    J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulations and nebulizer performance.
    O'Riordan TG
    Respir Care; 2002 Nov; 47(11):1305-12; discussion 1312-3. PubMed ID: 12425745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
    Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
    Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro comparison of DeVilbiss jet and ultrasonic nebulizers.
    Newman SP; Pellow PG; Clarke SW
    Chest; 1987 Dec; 92(6):991-4. PubMed ID: 3677844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-infective aerosols].
    Diot P; Dequin PF; Rivoire B; Gagnadoux F; Faurisson F; Diot E; Boissinot E; Lemarié E
    Rev Mal Respir; 1999 Jun; 16(3):277-85. PubMed ID: 10472633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.